Latest Breaking News On - Alaunos therapeutics - Page 8 : vimarsana.com

Form 8-K Alaunos Therapeutics, For: Mar 29

Alaunos Therapeutics to Participate in Upcoming Investor

HOUSTON, March 29, 2023 (GLOBE NEWSWIRE) Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), a leading T-cell receptor (TCR) cell.

Alaunos Therapeutics to Participate in Upcoming Investor Conferences in April

29.03.2023 - HOUSTON, March 29, 2023 (GLOBE NEWSWIRE) - Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), a leading T-cell receptor (TCR) cell therapy company advancing a clinical-stage pipeline of therapeutics for solid tumors, today .

12 Best One Dollar Stocks to Buy According To Hedge Funds

In this article, we discuss 12 best one dollar stocks to buy according to hedge funds.

Worldwide TCR Therapy Industry to 2035: Market is Anticipated to be Driven by Nasopharyngeal Carcinoma, Multiple Myeloma and Head and Neck Carcinoma

/PRNewswire/ The "Global TCR Therapy Market, 2022-2035: Distribution by Target Indication, Target Antigen, Key Players and Key Geographies: Industry Trends.

Alaunos Therapeutics Announces Proposed Public Offering of Common Stock

Alaunos "checked all the boxes" with early data for cancer therapy – Cantor (NASDAQ:TCRT)

After over a 20% decline in the previous session, clinical-stage biotech Alaunos Therapeutics, Inc

Why Alaunos Therapeutics Triumphed On Tuesday

Four of the biotech's top managers reveal they've exercised stock options, and investors are following suit by snapping up shares.

Wall Street Thinks These 2 Nasdaq Stocks Could Go Parabolic Soon

NASH is a common disease, but there are no approved treatments for it. These two drug companies have promising candidates in clinical trials.

US Stocks Open Lower; Dow Tumbles 300 Points

U.S. stocks traded lower this morning, with the Dow Jones dropping around 300 points on Friday. Following the market opening Friday, the Dow trad.